H2 receptor Selective Agonists | Antagonists
|Catalog No.||Product Name||Information||Selective / Pan||IC50 / Ki|
Nizatidine is a histamine H2 receptor antagonist with IC50 of 0.9 nM, also inhibits AChE with IC50 of 6.7 μM.
|Selective||Histamine H2 receptor, IC50: 0.9 nM|
|S1880||Roxatidine Acetate HCl||
Roxatidine Acetate HCl is a specific and competitive histamin H2-receptor antagonist, with IC50 of 3.2 μM, inhibits gastric acid secretion and ulcer formation.
|Selective||Histamine H2 receptor, IC50: 3.2 μM|
Ranitidine is a histamine H2-receptor antagonist with IC50 of 3.3 ± 1.4 μM.
|Selective||Histamine H2 receptor, IC50: 3.3 μM|
Cimetidine, a histamine congener, competitively inhibits histamine binding to histamine H2 receptors.
Famotidine is a histamine H2–receptor antagonist with IC50 of 0.6 mM, commonly used to treat heartburn, GERD, ulcers, and other digestive conditions.
Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.
Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.
Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2.